Source link : https://newshealth.biz/health-news/first-in-class-drug-approved-for-iga-nephropathy/
(MedPage Today) — The FDA granted accelerated approval to atacicept (Trutakna) to reduce proteinuria in adults with primary IgA nephropathy at risk for disease progression. Data from ORIGIN 3 supported approval of the once-weekly self-administered… Source link : https://www.medpagetoday.com/nephrology/generalnephrology/122087 Author : Publish date : 2026-07-07 20:51:00 Copyright for syndicated content belongs to the linked Source.
The post First-in-Class Drug Approved for IgA Nephropathy first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-07 20:51:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8